Trials / Completed
CompletedNCT02161159
An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 515 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate real world pattern of use of BOTOX® in actual clinical practice in patients with idiopathic overactive bladder (iOAB) with urinary incontinence whose symptoms have not been adequately managed by oral anticholinergic therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | botulinum toxin Type A administered in accordance with physician standard practice. |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-06-11
- Last updated
- 2016-04-18
Locations
54 sites across 4 countries: Germany, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02161159. Inclusion in this directory is not an endorsement.